112 related articles for article (PubMed ID: 30036381)
1. Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas.
Torres KL; Mariño JM; Pires Rocha DA; de Mello MB; de Melo Farah HH; Reis RDS; Alves VDCR; Gomes E; Martins TR; Soares AC; de Oliveira CM; Levi JE
PLoS One; 2018; 13(7):e0201262. PubMed ID: 30036381
[TBL] [Abstract][Full Text] [Related]
2. Performance of OncoE6 cervical test with collection methods enabling self-sampling.
Krings A; Dückelmann AM; Moser L; Gollrad J; Wiegerinck M; Schweizer J; Kaufmann AM
BMC Womens Health; 2018 May; 18(1):68. PubMed ID: 29783960
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
4. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
Zhang Q; Dong L; Hu S; Feng R; Zhang X; Pan Q; Ma J; Zhang L; Zhao X; Sankaranarayanan R; Qiao Y; Zhao F
Int J Cancer; 2017 Sep; 141(6):1110-1119. PubMed ID: 28560716
[TBL] [Abstract][Full Text] [Related]
6. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
7. Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.
Ara R; Khatun S; Pervin S; Jahan M; Shahera U; Ferdous J; Begum SA; Fatema S; Begum M; Nazneen S; Goodman A
Gynecol Oncol; 2020 Sep; 158(3):590-596. PubMed ID: 32680634
[TBL] [Abstract][Full Text] [Related]
8. Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
Abedin S; Paul SK; Haque N; Ahmed S; Nasreen SA; Akhter N; Haque N; Sarkar SR; Roy S; Nahar F; Ahmed MU; Switzer J; Kobayashi N; Hossain MA; Chowdhury UW
Mymensingh Med J; 2019 Jan; 28(1):31-36. PubMed ID: 30755547
[TBL] [Abstract][Full Text] [Related]
9. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
10. [Role of HPV16/18/45 DNA testing of cervical specimens as a triage testing in cervical cancer screening].
Li J; Chen W; Kang LN; Chen F; Guo DP; Li BY; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):254-9. PubMed ID: 23827061
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
[TBL] [Abstract][Full Text] [Related]
12. OncoE6 Positivity among VIA Positive Suspected Cases from Colposcopy Clinic of Mymensingh Medical College Hospital, Mymensingh.
Nahar F; Hossain MA; Paul SK; Ahmed MU; Khatun S; Akhter N; Bhuiyan GR; Nasreen SA; Roy S; Barman TK; Laskar N; Begum H; Abedin S; Haque N; Ahmed S; Kobayashi N
Mymensingh Med J; 2017 Oct; 26(4):879-884. PubMed ID: 29208879
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China.
Yu LL; Kang LN; Zhao FH; Lei XQ; Qin Y; Wu ZN; Wang H; Chen W; Qiao YL
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1167-74. PubMed ID: 27197295
[TBL] [Abstract][Full Text] [Related]
14. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
17. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
[No Abstract] [Full Text] [Related]
18. Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.
Ilahi NE; Hashmi SN; Anwar S; Murad S
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2367-73. PubMed ID: 27573495
[TBL] [Abstract][Full Text] [Related]
19. Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay.
Oliveira CM; Musselwhite LW; de Paula Pantano N; Vazquez FL; Smith JS; Schweizer J; Belmares M; Possati-Resende JC; Vieira MA; Longatto-Filho A; Fregnani JHTG
PLoS One; 2020; 15(4):e0232105. PubMed ID: 32320451
[TBL] [Abstract][Full Text] [Related]
20. Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening.
Tamalet C; Le Retraite L; Leandri FX; Heid P; Garnier HS; Piana L
Clin Microbiol Infect; 2013 Jan; 19(1):E44-E50. PubMed ID: 23137168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
